BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

0.341

+0.026 (8.12%)

At close: Dec 20, 2024, 4:00 PM

0.342

+0.001 (0.26%)

After-hours: Dec 20, 2024, 7:10 PM EST

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $14.58 million as of December 20, 2024. Its market cap has decreased by -85.77% in one year.

Market Cap

14.58M

Enterprise Value

79.16M

1-Year Change

-85.77%

Ranking

#4979

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $14.58M, a decrease of -91.55%. That is a compound annual growth rate of -30.50%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	14.58M	-83.12%
Dec 29, 2023	86.35M	-85.65%
Dec 30, 2022	601.94M	5.82%
Dec 31, 2021	568.84M	-49.47%
Dec 31, 2020	1.13B	327.27%
Dec 31, 2019	263.49M	336.30%
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ProPhase Labs	15.76M
Traws Pharma	15.58M
Minerva Neurosciences	15.18M
Innovative Eyewear	14.26M
Streamline Health Solutions	14.08M
GlycoMimetics	14.08M
Acurx Pharmaceuticals	13.90M
ImmunoPrecise Antibodies	13.80M

Market Cap Rankings